Description Founded by leading psychiatrists, neuroscientists, and AI researchers, Reulay’s mission is to increase the quality of life and longevity for 2 billion humans by creating effective, scalable, and affordable digital health therapeutics. Reulay’s virtual therapeutic platform leverages machine learning across biometric, digital behavior, brain science, and epigenetic research to personalize evidence-based digital medicine that targets human biology for prevention and treatment. Reulay is advancing a broad pipeline of products across VR, AR, Mobile, and Web interventions to decrease stress and anxiety disorders, as well as associated chronic medical conditions such as cancer, stroke, heart disease and neurodegenerative diseases.
Address New York, US
Linkedin Source https://www.linkedin.com/company/reulay